{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:57:53Z","timestamp":1790456273835,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-27139-0","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T02:54:56Z","timestamp":1779850496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Informing life-course immunization and pandemic preparedness: a COVID-19 vaccine evaluation and HPV introduction experience in Sierra Leone"],"prefix":"10.1186","volume":"26","author":[{"given":"Desmond Maada","family":"Kangbai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald R.","family":"Mutebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela K.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Eleeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AbdulRaheem","family":"Yakubu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haurace","family":"Nyandemoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce M.","family":"Kallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminata","family":"Nunie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Nzirakaindi","family":"Ikoona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mame","family":"Toure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Michaels-Strasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"11","key":"27139_CR1","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/S1473-3099(17)30419-X","volume":"17","author":"FM Shearer","year":"2017","unstructured":"Shearer FM, Moyes CL, Pigott DM, Brady OJ, Marinho F, Deshpande A, et al. Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis. Lancet Infect Dis. 2017;17(11):1209\u201317.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"27139_CR2","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1377\/hlthaff.2011.0328","volume":"30","author":"FM LaForce","year":"2011","unstructured":"LaForce FM, Okwo-Bele J-M. Eliminating epidemic group A meningococcal meningitis in Africa through a new vaccine. Health Aff. 2011;30(6):1049\u201357.","journal-title":"Health Aff"},{"issue":"15","key":"27139_CR3","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.vaccine.2016.02.046","volume":"34","author":"X Huo","year":"2016","unstructured":"Huo X, Shi G, Li X, Lai X, Deng L, Xu F, et al. Knowledge and attitudes about Ebola vaccine among the general population in Sierra Leone. Vaccine. 2016;34(15):1767\u201372.","journal-title":"Vaccine"},{"issue":"suppl1","key":"27139_CR4","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1093\/infdis\/jiy020","volume":"217","author":"M Samai","year":"2018","unstructured":"Samai M, Seward JF, Goldstein ST, Mahon BE, Lisk DR, Widdowson M-A, et al. The Sierra Leone trial to introduce a vaccine against Ebola: an evaluation of rVSV\u2206 G-ZEBOV-GP vaccine tolerability and safety during the West Africa Ebola outbreak. J Infect Dis. 2018;217(suppl1):S6\u201315.","journal-title":"J Infect Dis"},{"key":"27139_CR5","doi-asserted-by":"publisher","unstructured":"Liu Y, Sandmann FG, Barnard RC, Pearson CA, Pastore R, Pebody R, et al. Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European Region: a mathematical modelling study. Lancet Reg Health Eur. 2022;12. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100267.","DOI":"10.1016\/j.lanepe.2021.100267"},{"key":"27139_CR6","unstructured":"UNICEF. COVID-19 vaccines shipped by COVAX arrive in Sierra Leone. 2021. published online March 8. https:\/\/www.unicef.org\/wca\/press-releases\/covid-19-vaccines-shipped-covax-arrive-sierra-leone\/. Accessed 20 June 2024."},{"key":"27139_CR7","unstructured":"World Health Organization. WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination; published online September 14, 2020. https:\/\/www.nitag-resource.org\/sites\/default\/files\/2020-09\/WHO-2019-nCoV-SAGE_Framework-Allocation_and_prioritization-2020. Accessed 5 July 2023."},{"key":"27139_CR8","unstructured":"Worldometer, editor. Sierra Leone Population (live). Dover: Worldometer; 2021. Available from: https:\/\/www.worldometers.info\/world-population\/sierra-leone-population\/.\u00a0Cited 2026 Feb 2."},{"key":"27139_CR9","unstructured":"Statistics SL. 2021 Mid-Term Population and Housing Census: Final Results. Freetown: Statistics Sierra Leone; 2021. Available from: https:\/\/www.statistics.sl\/index.php\/census\/census-2021.html.\u00a0Cited 2026 Feb 2."},{"key":"27139_CR10","doi-asserted-by":"crossref","unstructured":"Sheffel A, Andrews KG, Conner R, Di Giorgio L, Evans DK, Gatti R et al. Human resource challenges in health systems: evidence from 10 African countries. Health Policy Plann. 2024:czae034.","DOI":"10.1093\/heapol\/czae034"},{"issue":"10278","key":"27139_CR11","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(21)00306-8","volume":"397","author":"OJ Wouters","year":"2021","unstructured":"Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021;397(10278):1023\u201334.","journal-title":"Lancet"},{"key":"27139_CR12","doi-asserted-by":"publisher","unstructured":"Masresha B, Ruiz MAS, Atuhebwe P, Mihigo R. The first year of COVID-19 vaccine roll-out in Africa: challenges and lessons learned. Pan Afr Med J. 2022;41(Suppl 2):2. https:\/\/doi.org\/10.11604\/pamj.supp.2022.41.2.33686.","DOI":"10.11604\/pamj.supp.2022.41.2.33686"},{"issue":"4","key":"27139_CR13","doi-asserted-by":"publisher","first-page":"e059138","DOI":"10.1136\/bmjopen-2021-059138","volume":"12","author":"SLB Faye","year":"2022","unstructured":"Faye SLB, Krumkamp R, Doumbia S, Tounkara M, Strauss R, Ouedraogo HG, et al. Factors influencing hesitancy towards adult and child COVID-19 vaccines in rural and urban West Africa: a cross-sectional study. BMJ open. 2022;12(4):e059138.","journal-title":"BMJ open"},{"issue":"3","key":"27139_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"key":"27139_CR15","unstructured":"World Health Organization. Sierra Leone introduces Human Papilloma Virus vaccine to protect girls from cervical cancer; published online October 3, 2022. https:\/\/www.afro.who.int\/countries\/sierra-leone\/news\/sierra-leone-introduces-human-papilloma-virus-vaccine-protect-girls-cervical-cancer\/. Accessed 5 July 2023."},{"key":"27139_CR16","unstructured":"World Health Orgnanization. Considerations for integrating COVID-19 vaccination into immunization programmes and primary health care for 2022 and beyond. Published online: February 21, 2023. https:\/\/www.who.int\/publications\/i\/item\/9789240064454. Accessed 5 July 2023."},{"key":"27139_CR17","unstructured":"World Health Organization. COVID-19 vaccine post-introduction evaluation (cPIE). Published online August 25, 2021. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-cPIE-2021.1\/. Accessed 5 July 2023."},{"issue":"2","key":"27139_CR18","first-page":"72","volume":"57","author":"M Lakshminarasimhappa","year":"2022","unstructured":"Lakshminarasimhappa M. Web-based and smart mobile app for data collection: Kobo Toolbox\/Kobo collect. J Indian Libr Association Now Available https:\/\/journal ilaindia net\/. 2022;57(2):72\u20139.","journal-title":"J Indian Libr Association Now Available https:\/\/journal ilaindia net\/"},{"key":"27139_CR19","unstructured":"World Health Organization. COVID-19 national deployment and vaccination plan: submission and review process. 2021."},{"issue":"11","key":"27139_CR20","doi-asserted-by":"publisher","first-page":"e007271","DOI":"10.1136\/bmjgh-2021-007271","volume":"6","author":"MB Barrie","year":"2021","unstructured":"Barrie MB, Lakoh S, Kelly JD, Kanu JS, Squire JS, Koroma Z, et al. SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey. BMJ global health. 2021;6(11):e007271.","journal-title":"BMJ global health"},{"key":"27139_CR21","doi-asserted-by":"publisher","first-page":"949425","DOI":"10.3389\/fpubh.2022.949425","volume":"10","author":"Z Liu","year":"2022","unstructured":"Liu Z, Gao L, Xue C, Zhao C, Liu T, Tia A, et al. Epidemiological trends of coronavirus disease 2019 in Sierra Leone from March 2020 to October 2021. Front Public Health. 2022;10:949425.","journal-title":"Front Public Health"},{"key":"27139_CR22","first-page":"311","volume":"9","author":"K Kamara","year":"2023","unstructured":"Kamara K, Elduma A, Gebru G. Knowledge, Attitude and Practice Survey on Protective Behavioral Practices against Coronavirus Disease 2019 among Health Workers in Sierra Leone, 2020. J Infect Dis Epidemiol. 2023;9:311.","journal-title":"J Infect Dis Epidemiol"},{"key":"27139_CR23","doi-asserted-by":"publisher","unstructured":"Szilagyi P, Vann J, Bordley C, Chelminski A, Kraus R, Margolis P et al. Interventions aimed at improving immunization rates. Cochrane Database Syst Rev. 2002;(4):CD003941\u2013CD. https:\/\/doi.org\/10.1002\/14651858.CD003941.","DOI":"10.1002\/14651858.CD003941"},{"key":"27139_CR24","unstructured":"World Health Organization (WHO). Considerations for integrating COVID-19 vaccination into immunization programmes and primary health care for 2022 and beyond. Available online: https:\/\/iris.who.int\/handle\/10665\/366171\/ (Accessed on: July 10, 2024)."},{"issue":"1","key":"27139_CR25","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1080\/07853890.2021.2009128","volume":"53","author":"MO Ota","year":"2021","unstructured":"Ota MO, Badur S, Romano-Mazzotti L, Friedland LR. Impact of COVID-19 pandemic on routine immunization. Ann Med. 2021;53(1):2286\u201397.","journal-title":"Ann Med"},{"issue":"Suppl 1","key":"27139_CR26","first-page":"12","volume":"37","author":"BG Masresha","year":"2020","unstructured":"Masresha BG, Luce R Jr, Shibeshi ME, Ntsama B, N\u2019Diaye A, Chakauya J, et al. The performance of routine immunization in selected African countries during the first six months of the COVID-19 pandemic. Pan Afr Med J. 2020;37(Suppl 1):12.","journal-title":"Pan Afr Med J"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-27139-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27139-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27139-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:39:25Z","timestamp":1787611165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-27139-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["27139"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-27139-0","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"14 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This activity was classified as a quality assurance\/quality improvement initiative conducted in response to a public health intervention and therefore did not meet the regulatory definition of human subjects\u2019 research requiring full IRB oversight. Accordingly, we received a RASCAL correspondence confirming \u201cNot Human Subjects Research\u201d under 45 CFR 46, Protocol IRB AAAV6532 (Y01M00), Columbia University.In Sierra Leone, the study protocol underwent independent ethical review by the Sierra Leone Ethics and Scientific Review Committee (SLESRC), which determined that the study posed minimal risk to participants and granted approval for its implementation. All procedures were conducted in accordance with the ethical principles outlined in the Declaration of Helsinki (2013 revision) and the Council for International Organizations of Medical Sciences (CIOMS) International Ethical Guidelines for health-related research involving humans.Prior to each interview, verbal informed consent was obtained after participants were provided with a clear explanation of the study\u2019s purpose, procedures, and their rights. Participation was entirely voluntary, and participants were informed that refusal to answer specific questions or withdrawal at any time would not result in any adverse consequences. To ensure confidentiality, all personally identifying information was de-identified during data analysis. Completed interview forms were stored in locked cabinets, and only the research team had access to the data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have approved this manuscript for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"2442"}}